Morphologic changes after dihydrotestosterone (DHT) treatment.1A: Diffuse lobular atrophy (20x). by Jinho Lee (587173)

Subjects:

The tangential force between two particles with different equivalent diameters for P3: (a) elastic tangential contact force; (b) viscous tangential contact force. by Yongfeng Zhu (7361045)

Meta-analyses were performed to aggregate the HRs for continuous (A) and binary (B) GSRS after excluding the GSE167573 cohort. by Yu Zhang (12946)

Distribution (A) and association (B) between the identified clusters and the glucocorticoid signaling-related score (GSRS) stratification in the TCGA-KIRC cohort. by Yu Zhang (12946)

Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

Subjects:

Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

Subjects:

Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

Subjects:

Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

Subjects:

Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

Subjects:

Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

Subjects:

Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

Subjects:

Numbers of deaths, mortality rates, and 95% confidence intervals by age group, disease stage, and sex in China in 2021. by Xinyue Qi (9637055)

Subjects:

Disability-adjusted life years (DALYs), age-standardized DALY rates (ASDR), and 95% confidence intervals by age group, disease stage, and sex in China in 2021. by Xinyue Qi (9637055)

Subjects:

Numbers of deaths and disability-adjusted life years (DALYs) by disease stage in China from 1990 to 2021. by Xinyue Qi (9637055)

Subjects:

Deaths and DALYs from hepatitis B-related liver diseases in 1990 and 2021 and their change trends from 1990 to 2021. by Xinyue Qi (9637055)

Subjects:

Mortality rates and disability-adjusted life years (DALYs) rates by disease stage, sex, and age groups (<35, 35–49, 50–69, ≥ 70, and all ages) in China from 1990 to 2021. by Xinyue Qi (9637055)

Subjects:

Decomposition analysis of changes in hepatitis B virus (HBV) burden by region (China vs. Global), sex, and disease stage, 1990–2021. by Xinyue Qi (9637055)

Subjects:

Temporal trends of mortality of the total burden related to hepatitis B and three disease stages for all ages and across four age groups (<35, 35–49, 50–69, and ≥ 70 years) from 19... by Xinyue Qi (9637055)

Subjects:

Age-standardized mortality rates (ASMR), age-standardized disability-adjusted life year rates (ASDR), and their 95% uncertainty intervals (UIs) by disease stage in China from 1990... by Xinyue Qi (9637055)

Subjects:

BAPC model projections of mortality and DALYs rates for each disease stage in China from 2022 to 2035, with 50%, 60%, 70%, 80%, and 95% uncertainty intervals. by Xinyue Qi (9637055)

Subjects: